Practice Questions & Guide Exam Questions and
Answers with Explanation (Latest ):
Most Comprehensive to Pass the Exam, 100%
Verified – UPDATED.
,
, Based on the available search results, here is a comprehensive set of practice questions
and rationales for the WGU D116 Advanced Pharmacology Objective Assessment (OA).
These questions reflect the NP-level clinical scenarios, drug interactions, and evidence-
based prescribing guidelines emphasized in the exam .
Section 1: Pharmacokinetics & Pharmacodynamics (Core
Principles)
Question 1: Which of the following best describes pharmacokinetics?
A) The study of drug effects on the body
B) The study of drug absorption, distribution, metabolism, and excretion (ADME)
C) The study of drug toxicity
D) The study of drug interactions
Correct Answer: B
Rationale: Pharmacokinetics (what the body does to the drug) encompasses absorption,
distribution, metabolism, and excretion (ADME). Pharmacodynamics (what the drug does
to the body) is the study of drug effects on the body .
Question 2: Which factor primarily affects the absorption of orally administered drugs?
A) Renal clearance
B) First-pass metabolism
C) Volume of distribution
D) Plasma protein binding
Correct Answer: B
, Rationale: First-pass metabolism occurs when a drug is metabolized in the liver before
reaching systemic circulation, which can reduce the bioavailability of orally administered
drugs. Factors like pH, GI motility, and enzymatic activity also influence absorption .
Question 3: A drug with a half-life of 4 hours is administered every 4 hours.
Approximately how many half-lives are required to reach steady-state concentrations?
A) 1
B) 2
C) 4-5
D) 8
Correct Answer: C
Rationale: Steady-state is typically achieved after 4-5 half-lives, regardless of dosing
interval, because the amount of drug eliminated equals the amount administered over
time .
Question 4: Which of the following best defines bioavailability?
A) The fraction of a drug eliminated unchanged by the kidneys
B) The time it takes for the drug to reach half its maximum concentration
C) The fraction of an administered dose that reaches systemic circulation
D) The rate at which a drug binds to its receptor
Correct Answer: C
Rationale: Bioavailability is a measure of the extent of drug absorption and first-pass
metabolism—the fraction of an administered dose that reaches systemic circulation .
Question 5: A patient with hepatic cirrhosis has reduced metabolism of a drug that
undergoes extensive first-pass metabolism. The nurse expects: